International, expanded access program of everolimus in patients with metastatic renal cell carcinoma (mRCC) who progressed after previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy (VEGFr-TKI): Subanalysis from emerging growth market (EGM) countries.
Se-Hoon Lee
Consultant or Advisory Role - Bayer; Novartis; Pfizer
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pfizer
Expert Testimony - Bayer; Novartis; Pfizer
Suleyman Buyukberber
No relevant relationships to disclose
Yen-Chuan Ou
No relevant relationships to disclose
Jeremy David Shapiro
Consultant or Advisory Role - Merck
Ashok Panneerselvam
Employment or Leadership Position - Novartis
Ozlem Ocak Arikan
Employment or Leadership Position - Novartis
Hong-Ling Xue
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Igor Rusakov
No relevant relationships to disclose